消息称强生正洽谈收购Intra-Cellular 交易最快本周达成

观点新媒体
13 Jan

观点网讯:1月13日,资本市场消息,强生公司正在洽谈收购专注于治疗中枢神经系统疾病的生物制药公司Intra-Cellular Therapies,交易最快本周达成。另据知情人士透露,虽然讨论仍在进行,但也可能不会达成协议,而且还可能出现其他收购者。免责声明:本文内容与数据由观点根据公开信息整理,不构成投资建议,使用前请核实。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10